Clinical Trial Update: Revascularization of Stenosed Vessels Using Optimized Treatment of Rejuveinix for Reversing Endothelial Dysfunction [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 trial update on revascularization using Rejuveinix aiming to reverse endothelial dysfunction in critical limb ischemia and peripheral arterial disea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Limb Ischemia
• Peripheral Arterial Disease

Drugs mentioned

• Rejuveinix

Snippet

Sponsor: Reven Pharmaceuticals, Inc. | Conditions: Critical Limb Ischemia, Peripheral Arterial Disease | Phase 1, Phase 2 | Status: UNKNOWN